Use of bisphosphonates in cancer patients

被引:68
作者
Body, JJ
Coleman, RE
Piccart, M
机构
[1] FREE UNIV BRUSSELS, INST JULES BORDET, SUPPORT CARE CLIN, B-1000 BRUSSELS, BELGIUM
[2] FREE UNIV BRUSSELS, INST JULES BORDET, CLIN CHEMOTHERAPY, B-1000 BRUSSELS, BELGIUM
[3] UNIV SHEFFIELD, WESTON PARK HOSP, YCRC DEPT CLIN ONCOL, SHEFFIELD S5 7AU, S YORKSHIRE, ENGLAND
关键词
D O I
10.1016/S0305-7372(96)90020-1
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
[No abstract available]
引用
收藏
页码:265 / 287
页数:23
相关论文
共 102 条
[1]   ESTROGEN-RECEPTOR STATUS - IMPORTANT VARIABLE IN PREDICTING RESPONSE TO ENDOCRINE THERAPY IN METASTATIC BREAST-CANCER [J].
ALLEGRA, JC ;
LIPPMAN, ME ;
THOMPSON, EB ;
SIMON, R ;
BARLOCK, A ;
GREEN, L ;
HUFF, KK ;
DO, HMT ;
AITKEN, SC ;
WARREN, R .
EUROPEAN JOURNAL OF CANCER, 1980, 16 (03) :323-331
[2]   ALENDRONATE DISTRIBUTED ON BONE SURFACES INHIBITS OSTEOCLASTIC BONE-RESORPTION IN-VITRO AND IN EXPERIMENTAL HYPERCALCEMIA MODELS [J].
AZUMA, Y ;
SATO, H ;
OUE, Y ;
OKABE, K ;
OHTA, T ;
TSUCHIMOTO, M ;
KIYOKI, M .
BONE, 1995, 16 (02) :235-245
[3]   Management of myeloma with bisphosphonates [J].
Bataille, R .
NEW ENGLAND JOURNAL OF MEDICINE, 1996, 334 (08) :529-530
[4]   EFFECT OF DAILY ETIDRONATE ON THE OSTEOLYSIS OF MULTIPLE-MYELOMA [J].
BELCH, AR ;
BERGSAGEL, DE ;
WILSON, K ;
OREILLY, S ;
WILSON, J ;
SUTTON, D ;
PATER, J ;
JOHNSTON, D ;
ZEE, B .
JOURNAL OF CLINICAL ONCOLOGY, 1991, 9 (08) :1397-1402
[5]   Efficacy of pamidronate in reducing skeletal events in patients with advanced multiple myeloma [J].
Berenson, JR ;
Lichtenstein, A ;
Porter, L ;
Dimopoulos, MA ;
Bordoni, R ;
George, S ;
Lipton, A ;
Keller, A ;
Ballester, O ;
Kovacs, MJ ;
Blacklock, HA ;
Bell, R ;
Simeone, J ;
Reitsma, DJ ;
Heffernan, M ;
Seaman, J ;
Knight, RD .
NEW ENGLAND JOURNAL OF MEDICINE, 1996, 334 (08) :488-493
[6]   AN EVALUATION OF THE POTENTIAL COST REDUCTIONS RESULTING FROM THE USE OF CLODRONATE IN THE TREATMENT OF METASTATIC CARCINOMA OF THE BREAST TO BONE [J].
BIERMANN, WA ;
CANTOR, RI ;
FELLIN, FM ;
JAKOBOWSKI, J ;
HOPKINS, L ;
NEWBOLD, RC .
BONE, 1991, 12 :S37-S42
[7]  
BODY J-J, 1992, Current Opinion in Oncology, V4, P624, DOI 10.1097/00001622-199208000-00005
[8]   TREATMENT OF TUMOR-INDUCED HYPERCALCEMIA WITH THE BISPHOSPHONATE PAMIDRONATE - DOSE-RESPONSE RELATIONSHIP AND INFLUENCE OF TUMOR TYPE [J].
BODY, JJ ;
DUMON, JC .
ANNALS OF ONCOLOGY, 1994, 5 (04) :359-363
[9]  
BODY JJ, 1993, J BONE MINER RES, V8, P701
[10]  
BODY JJ, 1989, J BONE MINER RES, V4, P923